Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms

6 de julho de 2026 atualizado por: Mikhail Volokitin, MD, DO., The Touro College and University System

Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they are associated with symptoms experienced by otherwise healthy people.

The purpose of this study is to determine the prevalence of Chapman Reflex Points in young healthy adults and to evaluate whether the presence and distribution of these points are associated with self-reported visceral symptoms. Participants complete a standardized health questionnaire regarding recent and recurrent symptoms and undergo a blinded physical examination of established Chapman Reflex Point locations performed by a trained investigator. The results of this study may improve understanding of the physiological mechanisms underlying Chapman Reflex Points and help clarify their potential role in preventive osteopathic assessment and early identification of altered autonomic, lymphatic, fascial, or neuroendocrine function.

Visão geral do estudo

Descrição detalhada

Chapman Reflex Points (CRPs) are discrete palpable nodules located within deep fascial tissues that have historically been interpreted as viscerosomatic reflex manifestations associated with dysfunction of specific internal organs. Traditional osteopathic models suggest that CRPs develop secondary to altered autonomic activity and lymphatic dysfunction resulting from visceral pathology. More recent mechanobiological investigations have proposed that fascial contractility mediated by myofibroblasts, sympathetic regulation of lymphatic vessel function, connective tissue remodeling, and neuroendocrine influences may contribute to the formation and persistence of these palpable findings.

Despite their longstanding use in osteopathic diagnosis and treatment, there is limited evidence regarding the prevalence of CRPs in healthy individuals, and relatively few studies have investigated whether the presence of CRPs correlates with self-reported visceral symptoms in populations without significant underlying disease. Improved characterization of CRP prevalence and symptom associations may provide insight into whether these findings represent markers of overt pathology, subclinical physiological modulation, or normal biological variation.

This study was designed as a cross-sectional observational investigation to evaluate the prevalence and distribution of CRPs in a young adult population and to explore potential relationships between CRP findings and participant-reported visceral symptoms. Participants completed a standardized health questionnaire designed to assess demographic characteristics, medical history, lifestyle factors, and recent or recurrent symptoms across multiple organ systems. Following questionnaire completion, participants underwent a systematic palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent palpatory techniques, including standardized pressure application and examination duration, were utilized to improve examination reproducibility.

Participant data were recorded using anonymized study identification numbers to maintain confidentiality. Statistical analyses were performed using Microsoft Excel and STATA software. Descriptive statistics were used to characterize participant demographics and CRP prevalence. Sex-based differences in total CRP counts were evaluated using Welch's two-sample t-test. Associations between individual Chapman Reflex Points and symptom clusters were assessed using stepwise regression analyses, while relationships between grouped CRPs and grouped visceral symptom scores were examined using bivariate linear regression techniques. Statistical significance was defined as a two-sided p-value of less than 0.05.

The findings from this study are intended to contribute to a contemporary understanding of Chapman Reflex Point physiology by integrating concepts related to autonomic regulation, lymphatic function, fascial mechanotransduction, and endocrine modulation. Further investigation may help clarify the potential utility of CRPs as markers of early physiological alterations and inform their role in preventive osteopathic assessment and individualized patient evaluation.

Tipo de estudo

Observacional

Inscrição (Real)

101

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • New York
      • New York, New York, Estados Unidos, 10027
        • Touro College of Osteopathic Medicine - Harlem

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Método de amostragem

Amostra Não Probabilística

População do estudo

Young adult volunteers recruited from an osteopathic medical school community participated in this cross-sectional observational study. Participants completed a standardized questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms, followed by a blinded palpatory examination of established Chapman Reflex Point locations performed by a trained investigator. A total of 101 participants were enrolled, with a mean age of 27 years.

Descrição

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Ability to understand the study procedures and provide informed consent.
  • Willingness to complete a standardized health questionnaire.
  • Willingness to undergo a blinded palpatory examination of established Chapman Reflex Point locations.

Exclusion Criteria:

  • Individuals younger than 18 years of age.
  • Inability or unwillingness to provide informed consent.
  • Inability or unwillingness to complete the health questionnaire.
  • Inability or unwillingness to undergo the palpatory examination.
  • Pregnancy.
  • Incomplete study data or questionnaire responses.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Healthy Young Adults
Participants were young adults who completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms. Participants subsequently underwent a blinded palpatory examination of established Chapman Reflex Point locations performed by a trained investigator. No therapeutic intervention was administered. The study evaluated the prevalence and distribution of Chapman Reflex Points and their associations with self-reported visceral symptom clusters.
Participants underwent a standardized palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent pressure application and examination duration were utilized to optimize reliability and reproducibility of palpatory findings. No therapeutic intervention, osteopathic manipulative treatment, medication administration, or other clinical intervention was provided as part of the study. Participants also completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms.
Outros nomes:
  • Chapman Reflex Point Assessment
  • Palpatory Examination of Chapman Reflex Points

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Prevalence of Chapman Reflex Points
Prazo: through study completion, an average of 1 year
The prevalence and distribution of Chapman Reflex Points identified during a standardized palpatory examination of established Chapman Reflex Point locations performed by a blinded trained investigator. The total number of Chapman Reflex Points observed per participant was recorded and summarized using descriptive statistics.
through study completion, an average of 1 year

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Association Between Chapman Reflex Points and Visceral Symptom Clusters
Prazo: through study completion, an average of 1 year
Associations between organ system-specific Chapman Reflex Point counts and self-reported visceral symptom clusters were evaluated using stepwise regression analyses and bivariate linear regression models.
through study completion, an average of 1 year
Sex Differences in Chapman Reflex Point Prevalence
Prazo: through study completion, an average of 1 year
Differences in the total number of Chapman Reflex Points identified among male and female participants were assessed using Welch's two-sample t-test.
through study completion, an average of 1 year

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Distribution of Organ System-Specific Chapman Reflex Points
Prazo: through study completion, an average of 1 year
The frequency of Chapman Reflex Points corresponding to individual organ systems, including pulmonary and lower gastrointestinal groupings, was assessed descriptively.
through study completion, an average of 1 year

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

4 de março de 2020

Conclusão Primária (Real)

26 de junho de 2026

Conclusão do estudo (Real)

27 de junho de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

30 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

6 de julho de 2026

Primeira postagem (Real)

8 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

8 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

6 de julho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever